NASDAQ: IBRX · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

ImmunityBio Inc.

How ImmunityBio Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$9.3B

Price

$8.74

P/E

-9.3

EPS (TTM)

$-0.94

1-year return

261.2%

Dividend yield

0.0%

52-week range

$2.02–$10.51

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources